Cadila Healthcare informs about press release

05 Oct 2018 Evaluate

Cadila Healthcare has informed about press release titled ‘Zydus receives final approval from the USFDA for Exemestane Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

876.35 -22.40 (-2.49%)
19-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1744.35
Dr. Reddys Lab 1274.05
Cipla 1238.65
Zydus Lifesciences 876.35
Lupin 2253.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×